Vascular endothelial growth factor expression is an independent negative predictor in extrahepatic biliary tract carcinomas

scientific article published on 01 May 1999

Vascular endothelial growth factor expression is an independent negative predictor in extrahepatic biliary tract carcinomas is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID10472340

P2093author name stringKatoh H
Miyasaka Y
Fujita M
Fujioka Y
Morita T
Horita S
Nagashima K
Hida Y
P433issue3B
P407language of work or nameEnglishQ1860
P304page(s)2257-2260
P577publication date1999-05-01
P1433published inAnticancer ResearchQ326290
P1476titleVascular endothelial growth factor expression is an independent negative predictor in extrahepatic biliary tract carcinomas
P478volume19

Reverse relations

cites work (P2860)
Q47861428A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma
Q38650019Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers
Q35640101Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future
Q36287599Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
Q42818294Chemotherapy in gallbladder carcinoma
Q89170919Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial
Q36614705Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma
Q35583920Current management of gallbladder carcinoma
Q33372792EGFR expression in gallbladder carcinoma in North America
Q38642455Emerging molecular targets and therapy for cholangiocarcinoma
Q37765099Genetics of biliary tract cancers and emerging targeted therapies
Q38686339Immunotherapy of biliary tract cancer
Q38619219New Horizons for Precision Medicine in Biliary Tract Cancers
Q90308323New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma
Q38160836New and emerging treatment options for biliary tract cancer
Q84792092Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma
Q42635172Targeted medical therapy of biliary tract cancer: recent advances and future perspectives
Q30398807Targeting Angiogenesis in Biliary Tract Cancers: An Open Option
Q35000785Targeting metastatic upper gastrointestinal adenocarcinomas
Q44660500Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas

Search more.